View Article

  • Implementation of 3D Printing in Medicine – Future Perspectives

  • Mrs. Saraswati wani college of pharmacy ganegoan

Abstract

3D printing technology has emerged as a transformative force in modern medicine, enabling the precise fabrication of customized drug formulations, medical devices, and implants. This review discusses the potential of 3D printing in personalized medicine, its current applications, and future perspectives. The advantages, technological advancements, regulatory challenges, and potential barriers to widespread adoption are also explored.

Keywords

3D Printing, Personalized Medicine, Drug Formulation, Additive Manufacturing, Medical Innovation.

Introduction

3D printing, or additive manufacturing, has gained significant traction in the pharmaceutical and biomedical fields. It allows for layer-by-layer fabrication of medical products with high precision and customization. This review aims to highlight the current status of 3D printing in medicine and explore its potential future impact on drug development, personalized therapy, and patient-specific healthcare solutions.

Current Applications of 3D Printing in Medicine

3D printing is currently used to create patient-specific implants, prosthetics, surgical tools, and drug dosage forms. Spritam®, the first FDA-approved 3D-printed drug, demonstrates the feasibility of this technology in pharmaceutical manufacturing. Hospitals and research centers are also leveraging 3D printing for anatomical models and surgical planning.

Advantages and Technological Innovations

3D printing enables tailored drug dosages, complex geometries, and multi-drug combinations in a single tablet. Technologies such as fused deposition modeling (FDM), stereolithography (SLA), and selective laser sintering (SLS) are being adapted for pharmaceutical applications, offering rapid prototyping and high material efficiency.

Challenges and Regulatory Considerations

Despite its promise, 3D printing in medicine faces challenges such as high costs, technical limitations, regulatory uncertainty, and scalability. Quality control, reproducibility, and material safety are critical issues that must be addressed before large-scale implementation.

Future Perspectives

The future of 3D printing in medicine is highly promising. Advancements in bioprinting may enable the creation of living tissues and organs. Personalized drug printing at pharmacies or hospitals could revolutionize treatment delivery. With ongoing research, improved regulation, and reduced costs, 3D printing is poised to become an integral part of future healthcare.

CONCLUSION

3D printing represents a revolutionary approach to healthcare, offering customized solutions and enhancing patient outcomes. While challenges remain, continued innovation and collaboration between technology developers, pharmaceutical companies, and regulatory bodies will pave the way for its successful integration into mainstream medicine.

REFERENCES

  1. Norman J, Madurawe RD, Moore CMV, Khan MA, Khairuzzaman A. A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Additive Manufacturing. 2017;23:53-63.
  2. Alhnan MA, Okwuosa TC, Sadia M, Wan KW, Ahmed W, Arafat B. Emergence of 3D Printed Dosage Forms: Opportunities and Challenges. Pharm Res. 2016;33(8):1817-1832.
  3. Trenfield SJ, Awad A, Goyanes A, et al. 3D Printing Pharmaceuticals: Drug Development to Frontline Care. Trends Pharmacol Sci. 2018;39(5):440-451

Reference

  1. Norman J, Madurawe RD, Moore CMV, Khan MA, Khairuzzaman A. A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Additive Manufacturing. 2017;23:53-63.
  2. Alhnan MA, Okwuosa TC, Sadia M, Wan KW, Ahmed W, Arafat B. Emergence of 3D Printed Dosage Forms: Opportunities and Challenges. Pharm Res. 2016;33(8):1817-1832.
  3. Trenfield SJ, Awad A, Goyanes A, et al. 3D Printing Pharmaceuticals: Drug Development to Frontline Care. Trends Pharmacol Sci. 2018;39(5):440-451

Photo
Vivek Ghadage
Corresponding author

Mrs. Saraswati wani college of pharmacy ganegoan

Vivek Ghadage, Implementation of 3D Printing in Medicine – Future Perspectives, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 5, 2418-2419. https://doi.org/10.5281/zenodo.15423875

More related articles
Antifungal Resistance In Dermatophytosis Treatment...
Fida P, Sreejith K, Thabshira M, PP Shahda, Simakh AP, ...
Formulation And Evaluation Of Polyherbal Gel...
Palak, Dev Prakash Dahiya, Shalu Bharti, Chinu Kumari, ...
Lifestyle Intervention: The Quintessential tool to...
J.C Balachandar, Sanjeev Kumar Yadav, Amit Kumar Agrawal, S. Irsh...
Related Articles
Unlocking The Biological Potential of Quinolines: A Review ...
Laksmi Gopal R, Sreeja S, Ayshu S, Devika P S, Amina T, Devapriya S, Thrishala Kennady, ...
Assessing And Identifying The Most Commonly Occuring Infections And Antibiotics ...
Arkaydius Jyndiang, A. R. Shabaraya, Viresh K. Chandur, ...
Computational, Molecular Docking, ADME/T And AIM Investigations Of 7-(4-Nitrophe...
Dr. Poornima Devi, Dr. Virendra Kumar, Dr. Vikas Singh, Prof. Alka Singh, ...
Review on Regulatory Affairs in the Era of Artificial Intelligence: Roles, Needs...
Sushant Shinde , Prachi Telavane, Shubham Prabhu, Mohit Jadhav , ...
Antifungal Resistance In Dermatophytosis Treatment...
Fida P, Sreejith K, Thabshira M, PP Shahda, Simakh AP, ...
More related articles
Antifungal Resistance In Dermatophytosis Treatment...
Fida P, Sreejith K, Thabshira M, PP Shahda, Simakh AP, ...
Formulation And Evaluation Of Polyherbal Gel...
Palak, Dev Prakash Dahiya, Shalu Bharti, Chinu Kumari, ...
Lifestyle Intervention: The Quintessential tool to prevent and reverse Type 2 Di...
J.C Balachandar, Sanjeev Kumar Yadav, Amit Kumar Agrawal, S. Irshad Ahamed, A. Ayeshamariam, M. Jaya...
Antifungal Resistance In Dermatophytosis Treatment...
Fida P, Sreejith K, Thabshira M, PP Shahda, Simakh AP, ...
Formulation And Evaluation Of Polyherbal Gel...
Palak, Dev Prakash Dahiya, Shalu Bharti, Chinu Kumari, ...
Lifestyle Intervention: The Quintessential tool to prevent and reverse Type 2 Di...
J.C Balachandar, Sanjeev Kumar Yadav, Amit Kumar Agrawal, S. Irshad Ahamed, A. Ayeshamariam, M. Jaya...